Characterization of key genes of the renin–angiotensin system in mature feline adipocytes and during in vitro adipogenesis

Obesity is a growing health problem in humans as well as companion animals. In the development and progression of obesity‐associated diseases, the members of the renin–angiotensin system (RAS) are proposed to be involved. Particularly, the prevalence of type 2 diabetes mellitus in cats has increased enormously which is often been linked to obesity as well as to RAS. So far, reports about the expression of a local RAS in cat adipocytes are missing. Therefore, we investigated the mRNA expression of various RAS genes as well as the adipocyte marker genes adiponectin, leptin and PPAR‐γ in feline adipocytes using quantitative PCR. To characterize the gene expression during adipogenesis, feline pre‐adipocytes were differentiated into adipocytes in a primary cell culture and the expression of RAS key genes measured. All major RAS components were expressed in feline cells, but obvious differences in the expression between pre‐adipocytes and the various differentiation stages were found. Interestingly, the two enzymes ACE and ACE2 showed an opposite expression course. In addition to the in vitro experiments, mature adipocytes were isolated from subcutaneous and visceral adipose tissue. Significant differences between both fat depots were found for ACE as well as AT1 receptor with greater expression in subcutaneous than in visceral adipocytes. Visceral adipocytes had significantly higher adiponectin and PPAR‐γ mRNA level compared to the subcutaneous fat cells. Concerning the nutritional status, a significant lower expression of ACE2 was measured in subcutaneous adipocytes of overweight cats. In summary, the results show the existence of a potentially functional local RAS in feline adipose tissue which is differentially regulated during adipogenesis and dependent on the fat tissue depot and nutritional status. These findings are relevant for understanding the development of obesity‐associated diseases in cats such as diabetes mellitus.     

长链n-3多不饱和脂肪酸对肠上皮细胞促炎细胞因子基因mRNA表达的影响

本试验旨在探讨长链n-3多不饱和脂肪酸(LC n-3 PUFA)对肠上皮细胞促炎细胞因子基因mRNA表达的影响.试验选用大鼠肠上皮细胞系IEC-6细胞为模型,分为4个处理,分别为对照、脂多糖(LPS,1μg/mL)、LPS(1μg/mL)+二十二碳六烯酸(DHA,100 μmol/L)和LPS(l μg/mL)+二十碳五烯酸(EPA,100μmol/L),每个处理3个重复,每孔为1个重复.细胞先用DHA、EPA或等量二甲基亚砜(DHA和EPA的溶剂,对照)预处理48h,再用LPS处理3h,收集细胞提取总RNA,采用实时定量PCR方法分析肿瘤坏死因子-α(TNF-α)、白介素-1β(IL-1β)和白介素-6(IL-6)的基因mRNA表达水平的差异.结果表明:LPS极显著上调了细胞中TNF-α、IL-1 β和IL-6的基因mRNA表达水平(P＜0.01),EPA均极显著或显著削弱了细胞内LPS诱导的TNF-α(P＜0.01)、IL-1β(P ＜0.01)和IL-6的基因mRNA水平(P＜0.05)的上调,而DHA仅显著削弱了细胞内LPS诱导的IL-1β的基因mRNA水平的上调(P＜0.05).结果提示,LC n-3 PUFA在肠上皮细胞中具有抗炎作用,且在本试验条件下EPA的抗炎效果要优于DHA.     

Effect of dietary canola oil on long‐chain omega‐3 fatty acid content in broiler hearts

Young and healthy broilers are susceptible to sudden death syndrome (SDS), which is caused by cardiac arrhythmia. The long‐chain ‘fish‐type’ omega‐3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have cardioprotective anti‐arrhythmic effects in animals and humans. Raising the cardiac level of EPA and DHA in chickens may protect against SDS. However, fish oil as a source of EPA and DHA in poultry feed is costly and introduces undesirable properties to the meat. Whilst omega‐3 vegetable oils, such as canola oil, are cheaper and do not have a strong odour, they contain the short‐chain fatty acid α‐linolenic acid, which requires conversion to EPA and DHA after ingestion. We investigated the capacity for dietary canola oil to elevate cardiac EPA and DHA in broilers. Broilers were fed with diets containing either 3% canola oil or tallow, which is currently used in some commercial feeds. Upon completion of a 42 day feeding trial, canola oil significantly increased EPA and EPA + DHA in heart phospholipids relative to tallow. The elevation in cardiac EPA and EPA + DHA may provide anti‐arrhythmic effects and protect against SDS in poultry. This proof‐of‐concept biochemical study suggests that a larger study to assess the clinical outcome of SDS may be warranted.     

Adipose tissue gene expression in obese dogs after weight loss

Body weight (BW) mainly depends on a balance between fat storage (lipogenesis) and fat mobilization (lipolysis) in adipocytes. BW changes play a role in insulin resistance (IR), the inability of insulin target tissue to respond to physiological levels of insulin. This results in inhibition of lipogenesis and stimulation of lipolysis. Weight gain leads to IR whereas, weight loss improves insulin sensitivity (IS). The aim of this study was to evaluate the effect of weight loss and recovery of IS on the expression of genes involved in lipogenesis and lipolysis in weight losing dogs. Gene expression was studied in both subcutaneous and visceral adipose tissue. Obese dogs received a hypoenergetic low fat high protein diet (0.6 x NRC recommendation). Before and after weight loss, IS was assessed using the euglycaemic hyperinsulinaemic clamp. Gene expression of IRS-2, SREBP, intracellular insulin effectors, ACC, FAS, FABP, ADRP, PEPCK, lipogenesis key proteins, perilipin and HSL, lipolysis key proteins were quantified using real-time RT-PCR in subcutaneous and visceral fat. BW decreased from 15.2 +/- 0.5 to 11.4 +/- 0.4 kg (p < 0.05) over 78 +/- 8 days. When obese, dogs were insulin resistant. After weight loss, IS was improved. In the subcutaneous adipose tissue, the expression of only the IRS-2 was increased. In the visceral adipose tissue, the expression of the genes involved in the lipogenesis was decreased whereas one of the genes implied in the lipolysis did not change. The expression profile of genes involved in lipid metabolism, as measured after weight loss, is indicative for a lower lipogenesis after weight loss than in obese dogs. Our results also confirm dramatic differences in the lipid metabolism of visceral and subcutaneous fat. They should be completed by comparing gene expression during weight losing and normal weight steady state.     

Dose‐Titration Effects of Fish Oil in Osteoarthritic Dogs

Background: Food supplemented with fish oil improves clinical signs and weight bearing in dogs with osteoarthritis (OA). Objective: Determine whether increasing the amount of fish oil in food provides additional symptomatic improvements in OA. Animals: One hundred and seventy‐seven client‐owned dogs with stable chronic OA of the hip or stifle. Methods: Prospective, randomized clinical trial using pet dogs. Dogs were randomly assigned to receive the baseline therapeutic food (0.8% eicosopentanoic acid [EPA] + docosahexaenoic acid [DHA]) or experimental foods containing approximately 2‐ and 3‐fold higher EPA+DHA concentrations. Both veterinarians and owners were blinded as to which food the dog received. On days 0, 21, 45, and 90, serum fatty acid concentrations were measured and veterinarians assessed the severity of 5 clinical signs of OA. At the end of the study (day 90), veterinarians scored overall arthritic condition and progression of arthritis based on their clinical signs and an owner interview. Results: Serum concentrations of EPA and DHA rose in parallel with food concentrations. For 2 of 5 clinical signs (lameness and weight bearing) and for overall arthritic condition and progression of arthritis, there was a significant improvement between the baseline and 3X EPA+DHA foods (P=.04, .03, .001, .0008, respectively) but not between the baseline and the 2X EPA+DHA foods. Conclusions and Clinical Importance: Increasing the amount of fish oil beyond that in the baseline food results in dose‐dependent increases in serum EPA and DHA concentrations and modest improvements in the clinical signs of OA in pet dogs.     

The interaction between maternal and post‐hatch n‐3 fatty acid supplementation in broiler diets

This study investigated whether offspring from n‐3‐supplemented breeders have an enhanced performance and immune organ weight when fed a post‐hatch n‐3‐enriched diet in comparison with their control‐fed counterparts and the importance of timing of omega‐3 supplementation. Therefore, 480 Ross‐308 broiler breeder hens were fed one of four different diets (120/treatment). The control diet (CON) was a basal diet, rich in n‐6 fatty acids (FA). The three other diets were enriched in n‐3 FA, formulated to obtain a different EPA/DHA ratio of 1/1 (EPA = DHA), 1/2 (DHA) or 2/1 (EPA). At 33 weeks of age, eggs were incubated to obtain 1440 offspring. They were set up according to their maternal diet and sex in 48 pens of 30 chicks each (12 pens per maternal treatment: six male and six female). Half of the offspring were given a post‐hatch control diet, whereas to other half received an n‐3‐supplemented diet. Zootechnical performance was followed for starter, grower and finisher phase, and at the end of each phase two, chicks per pen were sacrificed to determine the weight of the immune organs. No interaction was found between maternal and post‐hatch n‐3 treatment for zootechnical performance. An interaction arose between the maternal and post‐hatch n‐3 supplementation for proportional bursa weight at day 1 and day 14 and proportional liver weight at day 14, but effects on immune organ weight were rather limited. Offspring post‐hatch n‐3 supplementation did not enhance maternal n‐3 supplementation.     

In vitro modulatory effect of ω-3 polyunsaturated fatty acid (EPA and DHA) on phagocytosis and ROS production of goat neutrophils

An in vitro study was carried out to examine the influence of two fish-oil-derived long chain ω-3 polyunsaturated fatty acids (PUFAs), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on goat polymorphonuclear leukocytes (PMN). Twelve Saanen healthy goats were used as blood donors. Neutrophils were isolated from blood and incubated with increasing concentration of EPA and DHA (25, 50, 100, 200 μM). Control samples were incubated in the absence of ω-3 PUFAs. Phagocytosis was evaluated by fluorescein-labeled Escherichia coli incorporation, while extracellular Reactive Oxygen Species (ROS) production was determined by cytochrome c reduction assay, which was selected among the others due to its specificity for extracellular superoxide anion release. Phagocytic activity was significantly increased by EPA (P < 0.05) and DHA (P < 0.01). Treating PMN with EPA does not affect extracellular ROS production which is, on the contrary, down-regulated by DHA. This effect was increased in experimental conditions which mimic pro-inflammatory challenges (stimulation with PMA).This study demonstrates that EPA and DHA may have beneficial effect on neutrophil function by increasing their phagocytosis activity and, in the meanwhile, decreasing the tissue damages due to extracellular release of ROS.     

Fatty Acid Taste Receptor GPR120 Activation by Arachidonic Acid,Eicosapentaenoic Acid,and Docosahexaenoic Acid in Chickens

It has been reported that the supplementation of chicken diet with polyunsaturated fatty acids (PUFAs) such as arachidonic acid (AA), eicosapentaenoic acid (EPA), or docosahexaenoic acid (DHA) affects the qualities of eggs and meat. Previous studies have shown that a functional fatty acid taste receptor, G protein-coupled receptor 120 (GPR120), is broadly expressed in chicken oral and gastrointestinal tissues, and chickens have a gustatory perception of oleic acid, which is a chicken GPR120 agonist. The aim of this study was to elucidate the role of chicken GPR120 in response to PUFAs in chicken diets. Ca²⁺ imaging analyses revealed that chicken GPR120 was activated by AA, EPA, and DHA in a concentration-dependent manner. These results suggest that chickens can detect PUFAs via GPR120 in the oral and gastrointestinal tissues, implying that chickens have a gustatory perception of PUFAs.     

Influence of an n‐3 long‐chain polyunsaturated fatty acid‐enriched diet on experimentally induced synovitis in horses

Dietary n‐3 long‐chain polyunsaturated fatty acid (LCPUFA) supplementation has previously been shown to modify joint‐related inflammation in several species, although information in the horse is lacking. We investigated whether dietary supplementation with n‐3 LCPUFA would modify experimentally induced synovitis in horses. Twelve, skeletally mature, non‐pregnant mares were randomly assigned to either a control diet (CONT) or an n‐3 long‐chain fatty acid‐enriched treatment diet (N3FA) containing 40 g/day of n‐3 LCPUFA for 91 days. Blood samples taken on days 0, 30, 60 and 90, and synovial fluid collected on days 0 and 90 were processed for lipid composition. On day 91, joint inflammation was stimulated using an intra‐articular (IA) injection of 100 ng of recombinant equine IL‐1beta (reIL‐1β). Synovial fluid samples taken at post‐injection hours (PIH) 0, 4, 8 and 24 were analysed for prostaglandin E₂ (PGE₂), matrix metalloproteinase (MMP) activity and routine cytology. Synovium and articular cartilage samples collected at PIH 8 were analysed for gene expression of MMP 1 and MMP 13, interleukin‐1beta (IL‐1β), cyclooxygenase 2 (COX‐2), tumour necrosis factor‐alpha and the aggrecanases, a disintegrin and metalloprotease with thrombospondin motifs (ADAMTS)‐4 and ADAMTS‐5. A 90‐day feeding period of n‐3 LCPUFA increased serum phospholipid and synovial fluid lipid compositions of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) compared to CONT horses. The reIL‐1β injection caused an inflammatory response; however, there was no effect of dietary treatment on synovial fluid PGE2 content and MMP activity. Synovial tissue collected from N3FA horses exhibited lower expression of ADAMTS‐4 compared to CONT horses. Despite the presence of EPA and DHA in the synovial fluid of N3FA horses, dietary n‐3 LCPUFA supplementation did not modify synovial fluid biomarkers compared to CONT horses; however, the lower ADAMTS‐4 mRNA expression in N3FA synovium warrants further investigation of n‐3 LCPUFA as a joint therapy.     

In vitro modulation of caprine monocyte immune functions by ω-3 polyunsaturated fatty acids

The in vitro effects of the ω-3 polyunsaturated fatty acids (PUFAs) eicosapentanoic acid (EPA) and docosahexanoic acid (DHA) on phagocytosis and the extracellular respiratory burst in caprine monocytes were assessed. Blood monocytes incubated with increasing concentrations of EPA or DHA (25–200 μM) demonstrated increased phagocytosis compared to unexposed monocytes. Generation of reactive oxygen species (ROS) was not markedly affected in the presence of EPA and DHA, except at 200 μM, at which concentrations monocyte viability was also reduced.     

新西兰兔肌内和皮下前体脂肪细胞原代培养与诱导分化的研究

为建立新西兰兔前体脂肪细胞的体外培养模型,比较新西兰兔肌内和皮下前体脂肪细胞分化过程中相关基因的差异表达,实验采集 1 日龄新西兰兔背最长肌和皮下脂肪组织,采用胶原酶消化方法,分别从 2 种组织中分离前体脂肪细胞,进行细胞原代培养,绘制细胞生长曲线,并对肌内和皮下前体脂肪细胞诱导分化,利用 RT-PCR 检测相关基因的表达变化。结果表明:细胞在分离后 2 h 已经贴壁,24 h 时呈现出短梭形的细胞形态,第 2 天细胞变成长梭形,第 3 天进入对数生长期。肌内和皮下前体脂肪细胞在诱导分化后均被油红O 染色,皮下前体脂肪细胞的脂质积累在诱导分化的第 2 天显著高于肌内前体脂肪细胞(P<0.05);荧光定量结果表明,肌内和皮下前体脂肪细胞 CCAAT 增强子结合蛋白(C/EBPα)基因的表达趋势在诱导分化过程中相同,肌内前体脂肪细胞过氧化物酶体增殖激活受体(PPARγ)第 4 天的表达量显著高于第 6 天,而皮下前体脂肪细胞 PPARγ表达量差异不显著;肌内前体脂肪细胞脂蛋白脂肪酶(LPL)表达量在第 0天和第 2天差异不显著,而皮下前体脂肪细胞第 2 天显著高于第 0 天(P<0.05);肌内前体脂肪细胞脂肪酸合酶(FAS)基因第 0、2、4 天的表达量差异不显著,而皮下前体脂肪细胞第 2、4 天显著高于第 0 天(P<0.05)。本研究成功构建了新西兰兔肌内和皮下前体脂肪细胞的体外培养和诱导分化模型,并发现皮下前体脂肪细胞分化早于肌内前体脂肪细胞,为进一步研究新西兰兔前体脂肪细胞的分化机制和脂肪沉积奠定基础。     

Effects of soyabean meal‐ or whey‐based diets on lipid metabolism in weaned piglets

The present study aimed to test the hypothesis that dietary protein source influences lipid metabolism‐related parameters weaned piglets. The effects of soyabean meal (SB) and whey proteins (WP) on gene expression of several genes involved in the lipogenic process in liver, visceral (VAT) and subcutaneous (SAT) adipose tissues, plasma insulin concentration and fatty acid (FA) profile were investigated in 18 weaned piglets. Weaned piglets were fed one of two diets containing either SB or WP as the main protein source. Following a 10‐h fasting period, plasma insulin concentration and FA profile were assessed at 56 and 72 days of age, whereas gene expression in liver, VAT and SAT was assessed at 72 days of age. Plasma insulin concentration was not affected by diet, although it was 40% lower in SB fed pigs. The SB pigs had lower 14:0 (p < 0.01) and higher 18:3n‐3 (p < 0.001) levels in plasma in comparison with WP pigs. However, these changes were attributed to background differences in the dietary FA profile and not to a direct protein source effect. Gene expression of sterol regulatory element‐binding protein 1 (SREBP‐1) in liver and VAT were lower (p < 0.01 and p < 0.05, respectively) in SB compared to WP fed piglets, but no differences occurred in SAT. No changes were observed in sterol regulatory element‐binding protein 2, liver X receptor, peroxisome proliferator‐activated receptors α and γ and plasminogen activator inhibitor 1 mRNA levels, either in liver or in adipose tissues. In conclusion, dietary protein source, accompanied likely by side alterations in the dietary composition, affects lipid metabolism in pigs through the downregulation of SREBP‐1, which is a crucial determinant of lipogenic process.     

The effect of dietary long‐chain omega‐3 fatty acid supplementation on owner’s perception of behaviour and locomotion in cats with naturally occurring osteoarthritis

The aim of this randomized, double‐blinded, placebo–controlled, cross‐over designed study was to demonstrate the clinical effect, registered by a survey, of a 10‐week period of omega‐3 fatty acid supplementation of the diet (1.53 g eicosapentaenoic acid (EPA) and 0.31 g DHA, both per 1000 kcal ME, equivalent to the complete diet) of 16 cats with radiologically documented, naturally occurring osteoarthritis (OA), in comparison with a 10‐week period of supplementation with corn oil (0.00 g EPA and 0.00 g DHA, both per 1000 kcal ME). Cats on the fish oil revealed higher activity level (p = 0.07), more walking up and down the stairs (p = 0.07), less stiffness during gait (p = 0.03), more interaction with the owner (p = 0.07) and higher jumps (p = 0.03) compared to those on corn oil supplementation. In conclusion, supplementation of long‐chain omega‐3 polyunsaturated fatty acids changes the owner’s perception of some aspects of behaviour and locomotion in cats with naturally occurring OA.     

猪甘油三酯水解酶和激素敏感脂酶基因表达规律的研究

利用半定量RT-PCR法分析比较了甘油三酯水解酶(Triacylglycerol hydrolase,TGH)和激素敏感脂酶(Hormone-sensitive lipase,HSL)基因在不同猪种、不同发育阶段及不同部位脂肪组织中转录表达的差异,探讨其在猪脂肪组织的表达规律。结果显示,脂肪型个体TGHmRNA表达丰度显著低于瘦肉型和杂交型个体,成年猪较初生仔猪低,皮下、腹膜和内脏脂肪组织中TGH表达量依次递增;其变化规律与HSL相同。此外,对分离培养的原代前体脂肪细胞通过诱导分化和油红O染色区分分化状态,分析TGHmRNA表达的时序变化,发现TGH在前脂肪细胞中不转录表达,诱导分化后开始表达,且在诱导分化第4天表达量最高,分化第10天表达量下降,达到峰值的时间较HSL早。结果表明,TGH的表达与个体肥胖程度、年龄、脂肪组织部位以及脂肪细胞分化程度相关,同时,在脂肪细胞分化过程中,TGH表达峰值早于HSL,提示TGH在脂肪细胞发育过程中可能较早承担基础脂解作用。